Encompass Health Corporation (EHC) to Issue Quarterly Dividend of $0.21 on January 15th

Encompass Health Corporation (NYSE:EHC) declared a quarterly dividend on Thursday, October 22nd. Shareholders of record on Monday, January 4th will be paid a dividend of $0.21 per share on Friday, January 15th. This represents a $0.84 dividend on an annualized basis and a dividend yield of 0.7%. The ex-dividend date is Monday, January 4th.

Encompass Health has decreased its dividend payment by an average of 0.1% per year over the last three years and has raised its dividend annually for the last 2 consecutive years. Encompass Health has a dividend payout ratio of 15.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Encompass Health to earn $6.60 per share next year, which means the company should continue to be able to cover its $0.84 annual dividend with an expected future payout ratio of 12.7%.

Encompass Health Stock Down 1.4%

Shares of NYSE EHC opened at $124.23 on Friday. The stock has a market capitalization of $12.26 billion, a PE ratio of 20.23, a P/E/G ratio of 2.55 and a beta of 0.74. The company has a quick ratio of 1.19, a current ratio of 1.19 and a debt-to-equity ratio of 0.76. The firm has a fifty day moving average of $122.35 and a 200-day moving average of $112.46. Encompass Health has a 52-week low of $92.77 and a 52-week high of $129.96.

Encompass Health (NYSE:EHC) last issued its earnings results on Wednesday, August 5th. The company reported $1.55 earnings per share for the quarter, topping the consensus estimate of $1.48 by $0.07. Encompass Health had a return on equity of 18.08% and a net margin of 10.01%. The business had revenue of $1.60 billion for the quarter, compared to analyst estimates of $1.57 billion. During the same period last year, the company posted $1.40 EPS. The business’s quarterly revenue was up 9.6% on a year-over-year basis. Encompass Health has set its FY 2026 guidance at 6.020-6.250 EPS. On average, analysts anticipate that Encompass Health will post 6.08 EPS for the current year.

Insider Buying and Selling at Encompass Health

In other Encompass Health news, EVP John Darby sold 4,858 shares of the firm’s stock in a transaction dated Monday, August 31st. The stock was sold at an average price of $121.09, for a total value of $588,255.22. Following the transaction, the executive vice president directly owned 75,041 shares of the company’s stock, valued at $9,086,714.69. This trade represents a 6.08% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Mark Tarr sold 173,148 shares of the firm’s stock in a transaction dated Monday, August 10th. The shares were sold at an average price of $125.47, for a total value of $21,724,879.56. Following the completion of the transaction, the chief executive officer directly owned 267,814 shares in the company, valued at $33,602,622.58. This trade represents a 39.27% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Over the last quarter, insiders sold 186,912 shares of company stock valued at $23,434,845. 1.80% of the stock is owned by insiders.

Hedge Funds Weigh In On Encompass Health

A number of institutional investors and hedge funds have recently bought and sold shares of the stock. Live Oak Investment Partners raised its position in shares of Encompass Health by 2.0% in the 3rd quarter. Live Oak Investment Partners now owns 9,778 shares of the company’s stock valued at $1,188,000 after purchasing an additional 193 shares in the last quarter. Invested Advisors purchased a new position in shares of Encompass Health during the 3rd quarter valued at approximately $240,000. Signaturefd LLC boosted its stake in shares of Encompass Health by 107.1% during the 3rd quarter. Signaturefd LLC now owns 2,724 shares of the company’s stock valued at $331,000 after buying an additional 1,409 shares during the last quarter. Citizens Financial Group Inc. RI acquired a new stake in shares of Encompass Health during the third quarter worth approximately $262,000. Finally, Evergreen Capital Management LLC grew its position in shares of Encompass Health by 5.5% during the third quarter. Evergreen Capital Management LLC now owns 8,854 shares of the company’s stock worth $1,076,000 after buying an additional 460 shares in the last quarter. Hedge funds and other institutional investors own 97.25% of the company’s stock.

Encompass Health Company Profile

Encompass Health Corporation (NYSE:EHC) is a healthcare services company that operates inpatient rehabilitation hospitals in the United States and Puerto Rico. Its hospitals provide intensive rehabilitation to patients recovering from conditions such as stroke, brain and spinal cord injuries, neurological disorders, amputations, hip fractures and other serious illnesses or injuries.

The company’s services typically include nursing care, physical therapy, occupational therapy, speech and language therapy, respiratory therapy and medical management.